| 注册
首页|期刊导航|中药新药与临床药理|基于PTEN/AKT/mTOR通路探讨补心泻肺方改善慢性心力衰竭小鼠心肌纤维化的作用机制

基于PTEN/AKT/mTOR通路探讨补心泻肺方改善慢性心力衰竭小鼠心肌纤维化的作用机制

黄培红 孙丹淳 马惠旋 王远平 靳利利

中药新药与临床药理2026,Vol.37Issue(1):52-60,9.
中药新药与临床药理2026,Vol.37Issue(1):52-60,9.DOI:10.19378/j.issn.1003-9783.2026.01.006

基于PTEN/AKT/mTOR通路探讨补心泻肺方改善慢性心力衰竭小鼠心肌纤维化的作用机制

Mechanism of Buxin Xiefei Formula in Alleviating Myocardial Fibrosis in Mice with Chronic Heart Failure via the PTEN/AKT/mTOR Pathway

黄培红 1孙丹淳 2马惠旋 1王远平 2靳利利1

作者信息

  • 1. 广东省第二中医院,广东 广州 510095
  • 2. 广州中医药大学第五临床医学院,广东 广州 510095
  • 折叠

摘要

Abstract

Objective To investigate the effect and molecular mechanism of Buxin Xiefei Formula(BXXF)in improving myocardial fibrosis in mice with chronic heart failure(CHF)based on the PTEN/AKT/mTOR pathway.Methods A CHF model was established in C57/BL6J mice by intraperitoneal injection of isoproterenol hydrochloride(5 mg·kg-1,twice daily for 14 days).The mice were randomly divided into a control group,model group,low-dose BXXF(2.9 g·kg-1),medium-dose BXXF(5.8 g·kg-1),and high-dose BXXF group(11.6 g·kg-1),and a perindopril group(0.41 mg·kg-1).The BXXF groups and perindopril group were administered the corresponding drugs by gavage,while the control and model groups received an equal volume of saline for 4 weeks.Cardiac function was assessed using small-animal echocardiography to measure left ventricular ejection fraction(LVEF),left ventricular fractional shortening(LVFS),left ventricular end-diastolic volume(LVEDV),left ventricular end-systolic volume(LVESV),left ventricular end-diastolic diameter(LVEDD),and left ventricular end-systolic diameter(LVESD).Pathological changes in cardiac tissue were observed by HE staining,while myocardial fibrosis was evaluated by Masson staining.The mRNA expression levels of α-SMA,Collagen Ⅰ,and Collagen Ⅲ in cardiac tissue were detected by qRT-PCR,and the protein expression levels of α-SMA,Collagen Ⅰ,Collagen Ⅲ,PTEN,p-AKT,p-mTOR,AKT,and mTOR were measured by Western Blot.Results(1)Compared with the control group,the model group showed significantly decreased LVEF and LVFS values(P<0.01)and significantly increased LVEDD,LVESD,LVEDV,and LVESV values(P<0.01).HE staining revealed unclear myocardial cell boundaries,cell swelling,and local inflammatory cell infiltration in the model group.Masson staining indicated myocardial collagen deposition.The mRNA and protein expression levels of α-SMA,Collagen Ⅰ,and Collagen Ⅲ in cardiac tissue were significantly increased(P<0.01).PTEN protein expression was significantly elevated(P<0.01),while the p-AKT/AKT and p-mTOR/mTOR ratios were significantly decreased(P<0.01).(2)Compared with the model group,the low-,medium-,and high-dose BXXF groups exhibited significantly increased LVEF and LVFS(P<0.01)and significantly decreased LVEDD,LVESD,LVEDV,and LVESV(P<0.01).Pathological damage and fibrosis in cardiac tissue were markedly improved.The mRNA and protein expression levels of α-SMA,Collagen Ⅰ,and Collagen Ⅲ were significantly decreased(P<0.01).PTEN protein expression was significantly reduced(P<0.01),while the p-AKT/AKT and p-mTOR/mTOR ratios were significantly increased(P<0.01).Conclusion BXXF effectively improves cardiac function and inhibits ventricular remodeling in mice with CHF,and its mechanism may be associated with the regulation of PTEN/AKT/mTOR signaling pathway-mediated myocardial fibrosis.

关键词

补心泻肺方/慢性心力衰竭/心肌纤维化/心室重构/PTEN/AKT/mTOR通路/小鼠

Key words

Buxin Xiefei Formula/chronic heart failure/myocardial fibrosis/ventricular remodeling/PTEN/AKT/mTOR pathway/mice

引用本文复制引用

黄培红,孙丹淳,马惠旋,王远平,靳利利..基于PTEN/AKT/mTOR通路探讨补心泻肺方改善慢性心力衰竭小鼠心肌纤维化的作用机制[J].中药新药与临床药理,2026,37(1):52-60,9.

基金项目

国家自然科学基金-青年科学基金项目(82405259) (82405259)

广东省医学科学技术研究基金项目(A2024041) (A2024041)

广东省第二中医院科研创新基金项目-基础与应用基础研究青年启航项目(SEZYY2023A10) (SEZYY2023A10)

广东省第二中医院科研创新基金项目(SEZYY2023B18). (SEZYY2023B18)

中药新药与临床药理

1003-9783

访问量1
|
下载量0
段落导航相关论文